Skip to main content

Incyte ownership: holders and insider trading

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.66B

As filed, its directors and officers own 16.2% of the shares (proxy statement, 28 Apr 2026); 854 institutional managers reported holding 83.8% at 30 Jun 2026. Over the last twelve months, insiders sold $66.11M of shares on the open market, $66.11M of it under 10b5-1 plans set in advance, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
Felix J. BakerHolder · active31.2M15.6%Schedule 13D7 May 2026
Julian C. BakerInsider31.2M15.6%Proxy statement28 Apr 2026
Baker Bros. Advisors LP and affiliated entitiesHolder30.8M15.08%*Form 13F30 Jun 2026
The Vanguard Group and affiliatesHolder22.5M11.3%Proxy statement28 Apr 2026
VanguardInstitution20.6M10.10%*Form 13F30 Jun 2026
BlackRock, Inc.Holder18.0M8.84%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder12.6M6.32%Schedule 13G31 Mar 2026
Dodge & CoxHolder10.1M5%Schedule 13G30 Sep 2026
State StreetInstitution9.7M4.77%*Form 13F30 Jun 2026
Aqr Capital Management LLCInstitution5.3M2.61%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution4.8M2.33%*Form 13F30 Jun 2026
Lsv Asset ManagementInstitution4.1M2.02%*Form 13F30 Jun 2026
InvescoInstitution4.1M2.00%*Form 13F30 Jun 2026
Wellington ManagementInstitution3.6M1.75%*Form 13F30 Jun 2026
Renaissance Technologies LLCInstitution3.5M1.72%*Form 13F30 Jun 2026
Morgan StanleyInstitution2.9M1.45%*Form 13F30 Jun 2026
Arrowstreet Capital, Limited PartnershipInstitution2.7M1.35%*Form 13F30 Jun 2026
Robeco Institutional Asset Management B.V.Institution2.4M1.20%*Form 13F30 Jun 2026
Goldman SachsInstitution2.3M1.13%*Form 13F30 Jun 2026
Dimensional Fund AdvisorsInstitution2.3M1.12%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+8.5K$68.62$585.9K
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+12.3K$72.27$891.5K
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+16.4K$80.50$1.32M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+15.1K$74.78$1.13M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+23.5K$77.67$1.83M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+18.3K$61.76$1.13M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+19.7K$61.18$1.21M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+12.3K$64.25$790.6K
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+6.9K$68.25$471.4K
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+16.4K$85.01$1.40M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+12.7K$90.56$1.15M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+15.1K$83.58$1.26M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+24.8K$83.20$2.07M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+879$113.64$99.89K
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+18.0K$113.64$2.04M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Option exercise+19.1K$113.64$2.17M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Open-market sale (10b5-1 plan)−35.0K$116.06$4.07M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Open-market sale (10b5-1 plan)−22.3K$117.14$2.62M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Open-market sale (10b5-1 plan)−60.3K$118.27$7.13M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Open-market sale (10b5-1 plan)−74.0K$119.12$8.81M
Stein Steven H · CMO & Head of Late-Stage Dev.6 Nov 2026Open-market sale (10b5-1 plan)−48.6K$119.66$5.81M
Tray Thomas · Principal Accounting Officer3 Nov 2026Open-market sale (10b5-1 plan)−610$118.96$72.57K
CAGNONI PABLO J · President, Global Head of R&D15 Oct 2026Option exercise+839$71.93$60.35K
CAGNONI PABLO J · President, Global Head of R&D15 Oct 2026Option exercise+423$61.76$26.12K
CAGNONI PABLO J · President, Global Head of R&D15 Oct 2026Option exercise+455$61.18$27.84K

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

INCY in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.